A Case for a Neonatal, Low-Dose BCG Vaccination Trial

References

• Sanchez FO, Rodriguez JI, Agudelo G, Garcia LF. Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls. Infect Immun 1994; 62: 5673–8.
   PubMed Web of Science ®Google Scholar
• Surcel HM, Troye-Blomberg M, Paulie S, Andersson G, Moreno C, Pasvol G, et al. Th1/Th2 profiles in tuberculosis, based upon proliferation and the cytokine response of blood lymphocytes to mycobacterial antigens. Immunology 1994; 81: 171–6.
   PubMed Web of Science ®Google Scholar
• Lenzini L, Rottoli P, Rottoli L. The spectrum of human tuberculosis. Clin Exp Immunol 1977; 27: 230–7.
   PubMed Web of Science ®Google Scholar
• Bhatnagar R, Malaviya AN, Narayanan S, Rajgopalan P, Kumar R, Bharadwaj OP. Spectrum of immune responseabnormalities in different clinical forms of tuberculosis. Am Rev Respir Dis 1977; 115: 207–12.
   PubMed Web of Science ®Google Scholar
• Power CA. Immunology of BCG vaccination in mice: Implications for tuberculosis vaccination and for the use of BCG as a recombinant BCG vector. Doctoral thesis. Saskatoon: University of Saskatchewan; 2000.
   Google Scholar
• Bretscher PA, Wei G, Menon JN, Beilefeldt-Ohmann H. Establishment of stable cell-mediated immunity that makes ‘‘susceptible’’ mice resistant to Leishmania major. Science 1992; 257: 539–42.
   Google Scholar
• Menon JN, Bretscher PA. Parasite dose determines the Th1/Th2 nature of the response to Leishmania major independently of infection route and strain of host or parasite. Eur J Immunol 1998; 28: 4020–8.
   PubMed Web of Science ®Google Scholar
• Uzonna J, Wei G, Yurkowski D, Bretscher PA. The generation of distinct immune, pathophysiological states following Leishmania major infection in mice: Implications for immunological memory, vaccination and reactivation disease. Science (Submitted).
   Google Scholar
• Bancroft AJ, Else KJ, Grencis RK. Low level infection with Trichuris muris significantly affects the polarization of the CD4 response. Eur J Immunol 1994; 24: 3113–8.
   Google Scholar
• Menacci A, Spaccapelo R, delSero G, Enssle K-H, Cassone A, Bistoni F, et al. CD4 + T-helper-cell responses in mice with low-level Candida albicans infections. Infect Immun 1996; 64: 4907–14.
   Google Scholar
• Sacks DL, La1 SL, Shrivastava SN, Blackwell J, Neva FA. An analysis of T cell responsiveness in Indian Kala-azar. J Immunol 1987; 138: 908–13.
   Google Scholar
• Reiner SL, Locksley RM. The regulation of immunity to Leishmania major. Annu Rev Immunol 1995; 13: 151–77.
   PubMed Web of Science ®Google Scholar
• Ridley DS. Histological classification and the immunological spectrum of leprosy. Bull World Health Organ 1974; 51: 451–65.
   PubMedGoogle Scholar
• Yamamura M, Uyemura K, Deans RJ, Weinberg K, Rea TH, Bloom BR, et al. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 1993; 254: 277–9.
   Google Scholar
• Menon JN, Bretscher PA. Characterization of the immunological memory state generated in mice ‘‘susceptible’’ to Leishmania major following exposure to low doses of L. major and resulting in resistance to a normally pathogenic challenge. Eur J Immunol 1996; 26: 243–9.
   Google Scholar
• Power C, Wei G, Bretscher P. Mycobacterial dose defines the Th1/Th2 nature of the immune response independently of whether immunization is administered by the intravenous subcutaneous or intradermal route. Infect Immun 1998; 66: 5743–50.
   Google Scholar
• Hernandez-Pando R, Pavon L, Arriaga K, Orozco H, Madrid-Marina V, Rook G. Pathogenesis of tuberculosis in mice exposed to low and high doses of an environmental mycobacterial saprophyte before infection. Infect Immun 1997; 65: 3317–27.
   PubMed Web of Science ®Google Scholar
• Buddle BM, Delisle GW, Pfeiffer A, Aldwell FE. Immunological responses and protection against Mycobacterium bovis in calves vaccinated with a low dose of BCG. Vaccine 1995; 13: 1123.
   PubMed Web of Science ®Google Scholar
• Bretscher PA. A strategy to improve the efficacy of vaccination against tuberculosis and leprosy. Immunol Today. 1992; 13: 342–5.
   PubMedGoogle Scholar
• Ismail N, Bretscher P. The Th1/Th2 nature of concurrent immune responses to unrelated antigens can be independent. J Immunol 1999; 163: 4842–50.
   PubMedGoogle Scholar
• Sarzotti M, Robbins DS, Hoffman PM. Induction of protective CTL responses in newborn mice by a murine retrovirus. Science 1996; 271: 1726–8.
   Google Scholar
• Gray D, Matzinger P. T cell memory is short-lived in the absence of antigen. J Exp Med 1991; 174: 969–74.
   PubMedGoogle Scholar
• Dutton RW, Bradley LM, Swain SL. T cell memory. Annu Rev Immunol 1998; 16: 210–23.
   Google Scholar
• Stenger S, Donhauser N, Thuring H, Rollinghoff M, Bogdan C. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J Exp Med 1996; 183: 1501–14.
   Google Scholar
• Wolday D, Berhe N, Akuffo H, Britton S. Leishmania-HIV interaction: Immunopathogenic mechanisms. Parasitol Today 1999; 15: 182–7.
   PubMedGoogle Scholar
• Aebischer T, Moody FS, Handman F. Persistence of virulent Leishmania major in murine cutaneous leishmaniasia: a possible hazard for the host. Infect Immun 1993; 61: 220–6.
   Google Scholar
• Solbach W, Laskay T. The host response to leishmania infection. Adv Immunol 2000; 74: 275–317.
   PubMedGoogle Scholar
• Druilhe P, Perignon JL. Mechanisms of defense against P. faciparum asexual blood stage in humans. Immunol Lett 1994; 41: 115–20.
   PubMed Web of Science ®Google Scholar
• Taylor-Robinson AW. Immunoregulation of malarial infection: balancing the vices and virtues. lnt J Parasitol 1998; 28: 135–48.
   PubMedGoogle Scholar